课件：癌痛治疗与阿片类药物课件.pptVIP

THANK YOU SUCCESS * * 可编辑 A study to examine relationships among pain intensity and interferences in daily life in 176 hospitalized patients with cancer used the Brief Pain Inventory (BPI)-Short Form, which includes 4 pain-intensity items, 7 pain-interference items, and an estimate of pain relief, and the Pain Management Index (PMI). The BPI gives a numerical value to pain severity and the impact of pain on activities of daily life. Researchers have consistently used this scale, and even translated it for worldwide use.36 The prevalence of pain in the sample of 176 patients was 79%. Of the 139 patients who experienced pain, a strong positive correlation was found between worst pain intensity and interference with daily life, which was not appreciably affected by surgery or procedures conducted during hospitalization. The high level of adequate analgesics prescribed are inconsistent with the 46% of patients reporting severe worst pain, and although patients with metastatic disease reported greater pain intensity and interference than patients with localized disease, they were more likely to have adequate analgesics prescribed. This suggests that the PMI, as used in this study, may not reflect the actual analgesics administered to hospitalized patients, which raises questions about how these prescribed analgesics were administered versus prescribed.36 During the 1980s and 1990s, government agencies and medical societies issued guidelines that endorsed the value of opioid analgesics in the management of persistent cancer pain. These organizations included the World Health Organization, the Agency for Healthcare Research and Quality (formerly Agency for Health Care Policy and Research), and the American College of Physicians. The American Academy of Pain Medicine (AAPM) and American Pain Society (APS) published a consensus statement in order “to help foster a practice environment in which opioids may be used appropriately to reduce needless suffering from pain.” The